Országos Korányi Tbc és Pulmonológiai Intézet

ROR: 051mrhb02

OpenAlex ID: I4210163183

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

2016 · Martin Reck, Delvys Rodríguez-Abreu, et al. · New England Journal of Medicine · 10,058

Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater

2019 · Martin Reck, Delvys Rodríguez–Abreu, et al. · Journal of Clinical Oncology · 1,663

Exhaled breath condensate: methodological recommendations and unresolved questions

2005 · I. Horváth, J. Hunt, et al. · European Respiratory Journal · 1,280

PDF

Erlotinib as maintenance treatment in advanced non-small-cell lung cancer: a multicentre, randomised, placebo-controlled phase 3 study

2010 · Federico Cappuzzo, Tudor Ciuleanu, et al. · The Lancet Oncology · 1,186

Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%

2021 · Martin Reck, Delvys Rodríguez-Abreu, et al. · Journal of Clinical Oncology · 1,160

PDF

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

2023 · John V. Heymach, David Harpole, et al. · New England Journal of Medicine · 779

PDF

A European Respiratory Society technical standard: exhaled biomarkers in lung disease

2017 · Ildiko Horváth, Peter J. Barnes, et al. · European Respiratory Journal · 638

PDF

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

2016 · Johan F Vansteenkiste, Byoung Chul Cho, et al. · The Lancet Oncology · 511

A Randomized, Double-blind, Placebo-controlled Study of Tumor Necrosis Factor-α Blockade in Severe Persistent Asthma

2009 · Sally E. Wenzel, Peter J. Barnes, et al. · American Journal of Respiratory and Critical Care Medicine · 460

Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status

2014 · Jean-Yves Douillard, Gyula Ostoros, et al. · Journal of Thoracic Oncology · 448

PDF

First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study

2013 · J-Y Douillard, G Ostoros, et al. · British Journal of Cancer · 411

PDF

Therapeutic bronchoscopy with immediate effect: laser, electrocautery, argon plasma coagulation and stents

2006 · C. T. Bolliger, T. G. Sutedja, et al. · European Respiratory Journal · 380

Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions

2023 · Zsolt Megyesfalvi, Carl M. Gay, et al. · CA A Cancer Journal for Clinicians · 369

PDF

Alternative Vascularization Mechanisms in Cancer

2007 · Balázs Döme, Mary J.C. Hendrix, et al. · American Journal Of Pathology · 359

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)

2015 · G.R. Blumenschein, E.F. Smit, et al. · Annals of Oncology · 349

PDF

2017 · Julie R Brahmer, Delvys Rodríguez-Abreu, et al. · The Lancet Oncology · 348

A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer

2015 · G. Giaccone, L.A. Bazhenova, et al. · European Journal of Cancer · 279

Randomized Phase II Study of Dulanermin in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Advanced Non–Small-Cell Lung Cancer

2011 · Jean-Charles Soria, Zsuzsanna Márk, et al. · Journal of Clinical Oncology · 246

PDF

Vessel co‐option is common in human lung metastases and mediates resistance to anti‐angiogenic therapy in preclinical lung metastasis models

2016 · Victoria L Bridgeman, Peter B Vermeulen, et al. · The Journal of Pathology · 211

PDF

National smoking cessation support and care education program in Hungary National Centre for Smoking Cessation Support, National Koranyi Institute for Pulmonology, Budapest, Hungary

2018 · Erika Pataki, Márta Fényes, et al. · Tobacco Prevention & Cessation · 202

PDF

Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma

2002 · É. Huszár, G. Vass, et al. · European Respiratory Journal · 186

PDF

Air Pollution and Lung Cancer: A Review by International Association for the Study of Lung Cancer Early Detection and Screening Committee

2023 · Christine D. Berg, Joan H. Schiller, et al. · Journal of Thoracic Oncology · 179

PDF

ERS technical standard on bronchial challenge testing: pathophysiology and methodology of indirect airway challenge testing

2018 · Teal S. Hallstrand, Joerg D. Leuppi, et al. · European Respiratory Journal · 173

PDF

A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram-Negative Ventilator-Associated Pneumonia

2016 · Marin H. Kollef, Jean-Damien Ricard, et al. · CHEST Journal · 173

Heme Oxygenase-1: A Metabolic Nike

2013 · Barbara Wegiel, Zsuzsanna Nemeth, et al. · Antioxidants and Redox Signaling · 166

Works count: 1,252

Citation count: 75,040